Literature DB >> 22929871

Reliable biomarkers and predictors of schizophrenia and its treatment.

Anilkumar Pillai1, Peter F Buckley.   

Abstract

Biomarkers are chemical and physiologic parameters that can provide reliable and predictive information about the course and treatment of a given illness. Biomarkers are being increasingly sought after in other medical conditions, and in some instances (eg, breast cancer therapy) are beginning to be incorporated into clinical decision making. There is a confluence of research investigating potential biomarkers for schizophrenia. This article reviews early progress and strategies for evaluating biomarkers, as well as how this approach can advance the treatment of schizophrenia toward personalized medicine.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22929871     DOI： 10.1016/j.psc.2012.06.006

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN： 0193-953X


  8 in total

Review 1.  Biomarkers in psychosis: an approach to early identification and individualized treatment.

Authors:  Heline Mirzakhanian; Fiza Singh; Kristin S Cadenhead
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 2.  Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.

Authors:  Bradley Watmuff; Shaunna S Berkovitch; Joanne H Huang; Jonathan Iaconelli; Steven Toffel; Rakesh Karmacharya
Journal:  Mol Cell Neurosci       Date:  2016-01-14       Impact factor: 4.314

Review 3.  Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?

Authors:  Anthony O Ahmed; Peter F Buckley; Mona Hanna
Journal:  Curr Psychiatry Rep       Date:  2013-03       Impact factor: 5.285

Review 4.  A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels.

Authors:  Anthony O Ahmed; Samantha Kramer; Naama Hofman; John Flynn; Marie Hansen; Victoria Martin; Anilkumar Pillai; Peter F Buckley
Journal:  Neuropsychobiology       Date:  2021-03-11       Impact factor: 2.328

5.  Replicated evidence of absence of association between serum S100B and (risk of) psychotic disorder.

Authors:  Christine van der Leeuw; Machteld Marcelis; Sanne C T Peeters; Marcel M Verbeek; Paul P C A Menheere; Lieuwe de Haan; Jim van Os; Nico J M van Beveren
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

Review 6.  Theranostic Biomarkers for Schizophrenia.

Authors:  Matea Nikolac Perkovic; Gordana Nedic Erjavec; Dubravka Svob Strac; Suzana Uzun; Oliver Kozumplik; Nela Pivac
Journal:  Int J Mol Sci       Date:  2017-03-30       Impact factor: 5.923

Review 7.  The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders.

Authors:  A Cattaneo; N Cattane; V Begni; C M Pariante; M A Riva
Journal:  Transl Psychiatry       Date:  2016-11-22       Impact factor: 6.222

8.  Biclustered Independent Component Analysis for Complex Biomarker and Subtype Identification from Structural Magnetic Resonance Images in Schizophrenia.

Authors:  Cota Navin Gupta; Eduardo Castro; Srinivas Rachkonda; Theo G M van Erp; Steven Potkin; Judith M Ford; Daniel Mathalon; Hyo Jong Lee; Bryon A Mueller; Douglas N Greve; Ole A Andreassen; Ingrid Agartz; Andrew R Mayer; Julia Stephen; Rex E Jung; Juan Bustillo; Vince D Calhoun; Jessica A Turner
Journal:  Front Psychiatry       Date:  2017-09-26       Impact factor: 4.157
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.